Ortopedisk kirurgi
Kostnadsbesparelser
Systematisk og multimodal behandling
Multimodal patient blood management program based on a three-pillar strategy: a systematic review and meta-analysis. (åpner nytt vindu)
Kilde: Ann Surg 2019;269(5):794-804.
Saving blood and reducing costs: updating blood transfusion practice in lower limb arthroplasty. (åpner nytt vindu)
Kilde: Ir Med J 2018;111(4):730.
Preoperativ behandling av anemi
Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. (åpner nytt vindu)
Kilde: Br J Anaesth 2012;108(6):943-52.
Cost of post-operative intravenous iron therapy in total lower limb arthroplasty: a retrospective, matched cohort study. (åpner nytt vindu)
Kilde: Blood Transfus 2014;12(1):40-9.
Improved patient blood management and cost saving in hip replacement surgery through the implementation of pre-operative Sucrosomial® iron supplementation: a quality improvement assessment study. (åpner nytt vindu)
Kilde: Int Orthop 2019;43(1):39-46.
Clinical and budget impact of treating preoperative anemia in major orthopedic surgery--a retrospective observational study. (åpner nytt vindu)
Kilde: J Arthroplasty 2020;35(11):3084-8.
Hemostatika
Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). (åpner nytt vindu)
Kilde: J Bone Joint Surg Am 2013;95(21):1969-74.
Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). (åpner nytt vindu)
Kilde: J Bone Joint Surg Am 2013;95(21):1961-8.
Effect of epsilon aminocaproic acid on red-cell transfusion requirements in major spinal surgery. (åpner nytt vindu)
Kilde: Spine 2009;34(19):2096-103.
The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty. (åpner nytt vindu)
Kilde: J Orthop Surg 2017;25(1):2309499016684725.
An evaluation of the use of topical tranexamic acid in total knee arthroplasty. (åpner nytt vindu)
Kilde: J Arthroplasty 2013;28(8 Suppl):74-7.
Hemostatic techniques reduce hospital stay following multilevel posterior cervical spine surgery. (åpner nytt vindu)
Kilde: J Bone Joint Surg Am 2012;94(21):1952-8.
Comparing ε-aminocaproic acid and tranexamic acid in reducing postoperative transfusions in total knee arthroplasty. (åpner nytt vindu)
Kilde: J Knee Surg 2017;30(5):460-6.
Process improvement project using tranexamic acid is cost-effective in reducing blood loss and transfusions after total hip and total knee arthroplasty. (åpner nytt vindu)
Kilde: J Arthroplasty 2017;32(8):2375-80.
Comparing cost, efficacy, and safety of intravenous and topical tranexamic acid in total hip and knee arthroplasty. (åpner nytt vindu)
Kilde: Am J Orthop 2016;45(7):E439-43.
Effect of tranexamic acid on transfusion rates following total joint arthroplasty: a cost and comparative effectiveness analysis. (åpner nytt vindu)
Kilde: Orthop Clin North Am 2017;48(2):109-15.
Tranexamic acid decreases blood loss after total shoulder arthroplasty. (åpner nytt vindu)
Kilde: J Shoulder Elbow Surg 2016;25(4):614-8.
Tranexamic acid in patients with cancer undergoing endoprosthetic reconstruction: a cost analysis. (åpner nytt vindu)
Kilde: J Am Acad Orthop Surg 2021;29(22):961-9.
Topically applied epsilon-aminocaproic acid reduces blood loss and length of hospital stay after total knee arthroplasty. (åpner nytt vindu)
Kilde: Orthopedics 2017;40(6):e1044-9.
Does tranexamic acid reduce blood transfusion cost for primary total hip arthroplasty? A case-control study. (åpner nytt vindu)
Kilde: J Arthroplasty 2015;30(2):192-5.
Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. (åpner nytt vindu)
Kilde: Orthop Traumatol Surg Res 2012;98(5):477-83.
Using tranexamic acid for an additional 24 hours postoperatively in hip and knee arthroplasty saves money: a cost analysis from the TRAC-24 randomized control trial. (åpner nytt vindu)
Kilde: Bone Jt Open 2022;3(7):536-42.
Cost-benefit analysis of the use of tranexamic acid in total replacement hip surgery. (åpner nytt vindu)
Kilde: J Clin Anesth 2019;57:124-8.
Transfusion cost savings with tranexamic acid in primary total knee arthroplasty from 2009 to 2012. (åpner nytt vindu)
Kilde: J Arthroplasty 2015;30(3):365-8.
The efficacy, safety, and cost-effectives of combined administration of intravenous and local tranexamic acid in the management of patients undergoing primary total hip arthroplasty: a prospective, blinded and randomized clinical study. (åpner nytt vindu)
Kilde: Acta Orthop Traumatol Turc 2021;55(5):422-7.
Cost analysis of tranexamic acid in anemic total joint arthroplasty patients. (åpner nytt vindu)
Kilde: J Arthroplasty 2016;31(3):579-82.
Intravenous administration of tranexamic acid effectively reduces blood loss in primary total knee arthroplasty in a 610-patient consecutive case series. (åpner nytt vindu)
Kilde: Transfusion 2016;56(2):466-71.
Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. (åpner nytt vindu)
Kilde: BMJ 2014;349:g4829.
One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. (åpner nytt vindu)
Kilde: Clin Orthop Relat Res 2010;468(7):1905-11.
Pharmacologic hemostatic agents in total joint arthroplasty--a cost-effectiveness analysis. (åpner nytt vindu)
Kilde: J Arthroplasty 2018;33(7):2092-9.e9.
Use of a fibrin sealant within a blood-saving protocol in patients undergoing revision hip arthroplasty: effects on post-operative blood transfusion and healthcare-related cost analysis. (åpner nytt vindu)
Kilde: Int Orthop 2019;43(12):2707-14.
Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. (åpner nytt vindu)
Kilde: J Arthroplasty 2014;29(8):1512-5.
Perioperativ/intraoperativ blodsparing og blodgjenvinning
The safety, efficacy, and cost-effectiveness of intraoperative cell salvage in metastatic spine tumor surgery. (åpner nytt vindu)
Kilde: Spine J 2017;17(7):977-82.
Radiofrequency bipolar hemostatic sealer reduces blood loss, transfusion requirements, and cost for patients undergoing multilevel spinal fusion surgery: a case control study. (åpner nytt vindu)
Kilde: J Orthop Surg Res 2014;9:50.
Restrictive versus liberal red blood cell transfusion strategy after hip surgery: a decision model analysis of healthcare costs. (åpner nytt vindu)
Kilde: Transfusion 2017;57(2):357-66.
Cell saver for adult spinal deformity surgery reduces cost. (åpner nytt vindu)
Kilde: Spine Deform 2017;5(4):272-6.